These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 577471)

  • 1. Effect of prolactin and bromocriptine on growth of transplanted hormone-dependent mouse mammary tumours.
    Briand P; Thorpe SM; Daehnfeldt JL
    Br J Cancer; 1977 Jun; 35(6):816-21. PubMed ID: 577471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex hormone receptors in mammary tumours of GR mice.
    Sluyser M; Evers SG; De Goeij CC
    Nature; 1976 Sep; 263(5576):386-9. PubMed ID: 987544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of mammary tumorigenesis in GR mice with 2-bromo-alpha-ergocryptine.
    Welsch CW; Goodrich-Smith M; Brown CK; Wilson M
    Int J Cancer; 1979 Jul; 24(1):92-6. PubMed ID: 478693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of FCE 21336, a new prolactin lowering drug, on the MXT mouse mammary carcinoma.
    Zaccheo T
    Cancer Lett; 1985 Sep; 28(2):237-41. PubMed ID: 4052994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors.
    Janik P; Briand P; Hartmann NR
    Cancer Res; 1975 Dec; 35(12):3698-704. PubMed ID: 1192428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone-dependent mammary tumors in strain GR/A mice. III. Effectiveness of supplementary hormone treatments in inducing tumorous phase growth.
    Aidells BD; Daniel CW
    J Natl Cancer Inst; 1976 Sep; 57(3):527-37. PubMed ID: 978765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone-dependent mammary tumors in strain GR/A mice. II. Preneoplastic and neoplastic properties.
    Aidells BD; Daniel CW
    J Natl Cancer Inst; 1976 Sep; 57(3):519-26. PubMed ID: 978764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammary tumour development in BR6 mice: hormonal stimulation.
    Lee AE
    Br J Cancer; 1970 Sep; 24(3):568-73. PubMed ID: 4319943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ergolines as potential prolactin and mammary tumor inhibitors.
    Cassady JM; Floss HG
    Lloydia; 1977; 40(1):90-106. PubMed ID: 327183
    [No Abstract]   [Full Text] [Related]  

  • 10. A prolactin-dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumour dormancy.
    Wijsman JH; Cornelisse CJ; Keijzer R; van de Velde CJ; van Dierendonck JH
    Br J Cancer; 1991 Sep; 64(3):463-8. PubMed ID: 1911185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tamoxifen on growth and prolactin secretion of rat pituitary tumours.
    Prysor-Jones RA; Silverlight JJ; Jenkins JS
    J Endocrinol; 1983 May; 97(2):261-6. PubMed ID: 6854193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of mammary tumorigenesis in C3H/He mice by ovariectomy or treatment with 2-bromo-alpha-ergocryptine: a comparison.
    Welsch CW; Lambrecht LK; Hassett CC
    J Natl Cancer Inst; 1977 Apr; 58(4):1135-8. PubMed ID: 576623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bromocriptine on DNA synthesis, growth and hormone secretion of spontaneous pituitary tumours in the rat.
    Prysor-Jones RA; Jenkins JS
    J Endocrinol; 1981 Mar; 88(3):463-9. PubMed ID: 7217831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin receptors in mammary tumors of GR mice.
    Costlow ME; Sluyser M; Gallagher PE
    Endocr Res Commun; 1977; 4(5):285-94. PubMed ID: 204473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis of early preneoplastic lesions of the mammary gland.
    Welsch CW
    Cancer Res; 1976 Jul; 36(7 PT 2):2621-5. PubMed ID: 1277169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in concanavalin A-mediated agglutination of hormone-dependent mouse mammary tumour cells during serial transplantation.
    Sluyser M; van der Valk M; van Blitterswijk WJ
    Br J Cancer; 1980 Mar; 41(3):348-55. PubMed ID: 7387828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay of mouse prolactin. Prolactin levels in isograft-bearing orchidectomized mice.
    Boot LM; Kwa HG; Röpcke G
    Eur J Cancer (1965); 1973 Mar; 9(3):185-93. PubMed ID: 4787855
    [No Abstract]   [Full Text] [Related]  

  • 18. High tumour prolactin receptor content and lack of increase in serum prolactin levels as predictors of good response to endocrine therapy in rat mammary cancer.
    Di Carlo F; Muccioli G; Bellussi G; Conti G; Racca S
    Int J Cancer; 1988 May; 41(5):767-70. PubMed ID: 2966772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone and drug effects on growth of DMBA mammary tumours and plasma prolactin levels in adreno-ovariectomized rats.
    Minasian-Batmanian LC; Jabara AG
    Br J Cancer; 1981 Jun; 43(6):832-41. PubMed ID: 6788061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of biologic behavior and histology of transplanted mammary tumors in GR mice.
    Percy DH; Morris VL; MacInnes JI
    J Natl Cancer Inst; 1982 Oct; 69(4):933-8. PubMed ID: 6288995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.